Wave Life Sciences公布Inlight试验一期积极中期数据:单次注射WVE-007六个月后,体成分持续改善,内脏脂肪与腰围出现临床意义降低

美股速递
Mar 26

Wave Life Sciences近日披露了其Inlight临床试验一期研究的中期积极结果。数据显示,受试者在接受单剂WVE-007治疗六个月后,体成分指标呈现进一步优化。尤为关键的是,内脏脂肪与腰围测量值均实现具有临床意义的下降,这为该疗法在代谢相关疾病领域的应用潜力提供了重要依据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10